oxazolidin-2-one has been researched along with ciprofloxacin in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (10.26) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 14 (35.90) | 29.6817 |
| 2010's | 19 (48.72) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Mazzei, T; Mini, E; Novelli, A; Periti, P | 1 |
| Brumfitt, W; Gargan, RA; Hamilton-Miller, JM | 1 |
| Barry, AL | 1 |
| Daly, JS; Eliopoulos, GM; Moellering, RC; Reiszner, E | 1 |
| Trissel, LA; Williams, KY; Xu, QA; Zhang, Y | 1 |
| Georgopoulos, A; Graninger, W; Grisold, A; Mueller-Uri, P; Presterl, E | 1 |
| Grohs, P; Gutmann, L; Kitzis, MD | 1 |
| Banitt, LS; Barbachyn, MR; Evans, JM; Gage, JR; Gomez, M; Gordeev, MF; Hackbarth, C; Luehr, GW; Morin, SE; Parker, CN; Patel, DV; Trias, J; White, RJ; Zurenko, GE | 1 |
| Kinzig-Schippers, M; Naber, KG; Onda, H; Sörgel, F; Wagenlehner, FM; Wydra, S | 1 |
| Liu, J; Meng, QG; Wang, Q | 1 |
| Aktaş, E; Ayyildiz, A; Ertek, M; Parlak, M; Yazgi, H | 1 |
| Bergiers, C; Derue, G; Dujardin, JP; Frippiat, F; Michel, C | 1 |
| Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Jackson, MA; Selvarangan, R; Sharma, M; Thorell, EA; Woods, GM | 1 |
| Blanes, M; Morales, P; Pérez-Enguix, D; Ros, JA; Saiz, V; Santos, M | 1 |
| Knorr, JP; Moshfeghi, M; Sokoloski, MC | 1 |
| Jones, NP | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Johnson, AJ; Marker, DR; Martin, J; Mont, MA; Stroh, DA; Zywiel, MG | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Abshire, T; Brown, DL; Drusano, GL; Heine, HS; Holman, K; Kulawy, R; Liu, W; Louie, A; Vanscoy, BD | 1 |
| Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
| Holmberg, A; Mörgelin, M; Rasmussen, M | 1 |
| Brown, DL; Drusano, GL; Heine, HS; Kulawy, RW; Louie, A; VanScoy, BD | 1 |
| George, D; Gibson, G; Hardink, J; Lamb, L; Marra, A; Medina, I; O'Donnell, JP; Rugg, J; Van Deusen, J | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
| Ishii, F; Shimokawa, K; Takakuwa, R; Wada, Y; Yamazaki, N | 1 |
| Escribano, JA; Lozano, J; Rivin, E; Solivera, J; Vidal, E | 1 |
| Chopin, MC; Faure, K; Flateau, C; Guery, B; Harent, S; Vuotto, F; Wallet, F | 1 |
| Mansouri, S; Sadeghi, J | 1 |
| Cole, M; Fredlund, H; Jacobsson, S; Ringlander, J; Unemo, M; Wiggins, C | 1 |
| Andrews, B; Basarab, GS; Doig, P; Ehmann, DE; Fan, J; Gao, N; Kern, G; Mills, SD; Mueller, J; Palmer, T; Shapiro, AB; Sriram, S; Thresher, J; Walkup, GK | 1 |
| Alm, RA; Le, WJ; Li, S; Liu, YR; Mueller, JP; Rice, PA; Su, XH; Wan, C; Wang, BX | 1 |
| Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
| Choi, MJ; Hyun, BH; Jung, DY; Kang, HY; Lim, SK; Moon, DC; Na, SH; Oh, SJ | 1 |
| Goto, K; Itoh, H; Kai, M; Kitano, T; Ohchi, Y; Suzuki, Y; Tanaka, R; Tatsuta, R; Yasuda, N | 1 |
| Aanensen, D; Ahlstrand, J; Cole, MJ; Day, M; Golparian, D; Jacobsson, S; Sánchez-Busó, L; Unemo, M | 1 |
2 trial(s) available for oxazolidin-2-one and ciprofloxacin
| Article | Year |
|---|---|
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Topics: Acetamides; Adult; Anti-Infective Agents; Area Under Curve; Bacteria; Calibration; Cephalosporins; Ciprofloxacin; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Hydrogen-Ion Concentration; Linezolid; Male; Oxazolidinones; Quality Control; Serum Bactericidal Test | 2003 |
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Gonorrhea; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2021 |
37 other study(ies) available for oxazolidin-2-one and ciprofloxacin
| Article | Year |
|---|---|
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Glycopeptides; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1989 |
Variation in response of gram-positive cocci to the combination DuP 721 and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Gram-Positive Bacteria; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones | 1989 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |
Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Norfloxacin; Oxazoles; Oxazolidinones; Ribosomal Proteins; Staphylococcus; Streptococcus; Time Factors | 1988 |
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Drug Stability; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones | 2000 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Oxazolidinones; Polymerase Chain Reaction; Quinolines; Sensitivity and Specificity; Staphylococcus aureus; Teicoplanin; Vancomycin | 2001 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
Novel oxazolidinone-quinolone hybrid antimicrobials.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; DNA Topoisomerase IV; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Quinolones; Structure-Activity Relationship | 2003 |
[Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship; Sulbactam; Vancomycin | 2003 |
[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
Severe bilateral optic neuritis associated with prolonged linezolid therapy.
Topics: Acetamides; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Female; Functional Laterality; Humans; Linezolid; Optic Neuritis; Oxazolidinones; Prosthesis-Related Infections; Rifampin | 2004 |
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin | 2005 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Disseminated nontuberculous mycobacterial infections in sickle cell anemia patients.
Topics: Acetamides; Adolescent; Amikacin; Anemia, Sickle Cell; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Doxycycline; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Linezolid; Microbial Sensitivity Tests; Mycobacterium fortuitum; Mycobacterium Infections; Oxazolidinones; Treatment Outcome | 2006 |
Successful recovery after disseminated infection due to mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation--a case report.
Topics: Acetamides; Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cystic Fibrosis; Humans; Linezolid; Lung Transplantation; Male; Mycobacterium; Mycobacterium Infections; Oxazolidinones; Postoperative Complications; Sputum | 2007 |
Ciprofloxacin-induced Q-T interval prolongation.
Topics: Abscess; Acetamides; Adolescent; Anti-Infective Agents; Aztreonam; Bradycardia; Ciprofloxacin; Crohn Disease; Humans; Infusions, Intravenous; Linezolid; Long QT Syndrome; Male; Metronidazole; Oxazolidinones; Randomized Controlled Trials as Topic | 2008 |
Disseminated Nocardia infection with subretinal abscess.
Topics: Abscess; Acetamides; Adult; Anti-Infective Agents; Ciprofloxacin; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Linezolid; Nocardia; Nocardia Infections; Oxazolidinones; Retinal Diseases; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2010 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
Prophylactic oral antibiotics reduce reinfection rates following two-stage revision total knee arthroplasty.
Topics: Acetamides; Administration, Oral; Anti-Bacterial Agents; Antibiotic Prophylaxis; Arthroplasty, Replacement, Knee; Ciprofloxacin; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Knee Prosthesis; Linezolid; Oxazolidinones; Prevalence; Prospective Studies; Prosthesis-Related Infections; Reoperation; Retrospective Studies; Staphylococcal Infections; Staphylococcus; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.
Topics: Acetamides; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacterial Load; Bacterial Toxins; Ciprofloxacin; Diffusion Chambers, Culture; Infusion Pumps; Linezolid; Microbial Sensitivity Tests; Models, Biological; Oxazolidinones; Spores, Bacterial | 2012 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.
Topics: Acetamides; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Colony Count, Microbial; Enterococcus faecalis; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Oxazolidinones; Rifampin | 2012 |
Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Bacillus anthracis; Ciprofloxacin; Doxycycline; Fluoroquinolones; Linezolid; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Moxifloxacin; Oxazolidinones; Predictive Value of Tests; Quinolines; Spores, Bacterial; Thienamycins; Viral Load | 2012 |
Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Female; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Linezolid; Mice; Models, Animal; Oxazolidinones; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Survival Rate; Treatment Outcome | 2012 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®). Part 2: Adsorption of two drugs to Toraymyxin PMX-20R cartridges.
Topics: Acetamides; Adsorption; Anti-Bacterial Agents; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Endotoxins; Humans; Kinetics; Linezolid; Oxazolidinones; Polymyxin B; Renal Dialysis; Serum | 2013 |
Otogenic cerebellar abscess by Enterococcus avium, a very rare infectious agent.
Topics: Acetamides; Anti-Bacterial Agents; Brain Abscess; Cerebellar Diseases; Ciprofloxacin; Enterococcus; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Magnetic Resonance Imaging; Metronidazole; Middle Aged; Nervous System Diseases; Oxazolidinones; Tomography, X-Ray Computed | 2013 |
[Nocardia pseudobrasiliensis pneumonia in a heart transplant recipient].
Topics: Acetamides; Adult; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Heart Transplantation; Humans; Imipenem; Immunocompromised Host; Linezolid; Male; Nocardia; Nocardia Infections; Oxazolidinones; Pneumonia, Bacterial; Postoperative Complications; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 2013 |
Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Child; Child, Preschool; Ciprofloxacin; Clindamycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Exotoxins; Gentamicins; Humans; Infant; Iran; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Micrococcal Nuclease; Middle Aged; Oxazolidinones; Penicillin-Binding Proteins; Phenotype; Prevalence; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2014 |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Cefixime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Isoxazoles; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds | 2015 |
Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
Topics: Anti-Bacterial Agents; Barbiturates; Ciprofloxacin; Clinical Trials as Topic; DNA; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Gene Expression; Humans; Isoxazoles; Morpholines; Mutation; Neisseria gonorrhoeae; Oxazolidinones; Species Specificity; Spiro Compounds; Topoisomerase II Inhibitors | 2015 |
Multidrug-Resistant Neisseria gonorrhoeae Isolates from Nanjing, China, Are Sensitive to Killing by a Novel DNA Gyrase Inhibitor, ETX0914 (AZD0914).
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Ciprofloxacin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gene Expression; Gonorrhea; Humans; Isoxazoles; Male; Microbial Sensitivity Tests; Morpholines; Neisseria gonorrhoeae; Oxazolidinones; Spiro Compounds; Tetracycline; Topoisomerase II Inhibitors; Urethritis | 2016 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Detection of oxazolidinone and phenicol resistant enterococcal isolates from duck feces and carcasses.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ducks; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Feces; Genes, Bacterial; Linezolid; Microbial Sensitivity Tests; Multilocus Sequence Typing; Oxazolidinones; Republic of Korea; Ribosomal Protein L3; RNA, Ribosomal, 23S; Tetracycline; Thiamphenicol | 2019 |
Simultaneous quantification of plasma levels of 12 antimicrobial agents including carbapenem, anti-methicillin-resistant Staphylococcus aureus agent, quinolone and azole used in intensive care unit using UHPLC-MS/MS method.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Azoles; Carbapenems; Chromatography, High Pressure Liquid; Ciprofloxacin; Daptomycin; Doripenem; Drug Monitoring; Female; Fluconazole; Fluoroquinolones; Humans; Intensive Care Units; Levofloxacin; Linezolid; Male; Meropenem; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazines; Oxazolidinones; Quinolones; Tandem Mass Spectrometry; Tetrazoles; Voriconazole | 2021 |